Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum [Yahoo! Finance]
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up [Seeking Alpha]
Anbio Biotechnology (NASDAQ:NNNN) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Anbio Biotechnology (NASDAQ:NNNN) is now covered by analysts at
Weiss Ratings. They set a "sell (d+)" rating on the stock.